Jump to content

Recommended Posts

Posted

A Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Phase 2 Study to Evaluate the Safety and Efficacy of R-Verapamil in the Prophylaxis of Episodic Cluster Headache. - Study to Evaluate the Safety and Efficacy of R-Verapamil in the Prevention of Episodic Cluster Headache.

For more please see: https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003729-62/GB

Does anybody know more about this new study and about R-Verapamil?

Posted

Perhaps these research results are one of the reasons for the new study:

It is likely that clinical use of the R(+)-verapamil as an anti-inflammatory agent has potential therapeutic advantages. Given the effectiveness of these compounds at low concentrations and the broad spectrum of activity in inhibiting inflammatory responses, R(+)-verapamil appears to have significant potential in the treatment of chronic inflammatory neurological disorders.

Source:  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3014428/

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...